1. Home
  2. UNCY vs CCG Comparison

UNCY vs CCG Comparison

Compare UNCY & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • CCG
  • Stock Information
  • Founded
  • UNCY 2016
  • CCG 2014
  • Country
  • UNCY United States
  • CCG China
  • Employees
  • UNCY N/A
  • CCG N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • UNCY Health Care
  • CCG
  • Exchange
  • UNCY Nasdaq
  • CCG Nasdaq
  • Market Cap
  • UNCY 74.2M
  • CCG 84.5M
  • IPO Year
  • UNCY 2021
  • CCG N/A
  • Fundamental
  • Price
  • UNCY $4.42
  • CCG $0.90
  • Analyst Decision
  • UNCY Strong Buy
  • CCG Buy
  • Analyst Count
  • UNCY 5
  • CCG 1
  • Target Price
  • UNCY $41.60
  • CCG $350.00
  • AVG Volume (30 Days)
  • UNCY 459.6K
  • CCG 172.8K
  • Earning Date
  • UNCY 11-14-2025
  • CCG 11-25-2025
  • Dividend Yield
  • UNCY N/A
  • CCG N/A
  • EPS Growth
  • UNCY N/A
  • CCG N/A
  • EPS
  • UNCY N/A
  • CCG N/A
  • Revenue
  • UNCY N/A
  • CCG $444,290,042.00
  • Revenue This Year
  • UNCY N/A
  • CCG N/A
  • Revenue Next Year
  • UNCY $19,392.60
  • CCG $15.80
  • P/E Ratio
  • UNCY N/A
  • CCG N/A
  • Revenue Growth
  • UNCY N/A
  • CCG N/A
  • 52 Week Low
  • UNCY $3.71
  • CCG $0.71
  • 52 Week High
  • UNCY $11.00
  • CCG $1.54
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 43.93
  • CCG 32.96
  • Support Level
  • UNCY $4.32
  • CCG $0.93
  • Resistance Level
  • UNCY $4.63
  • CCG $1.05
  • Average True Range (ATR)
  • UNCY 0.29
  • CCG 0.07
  • MACD
  • UNCY -0.08
  • CCG -0.01
  • Stochastic Oscillator
  • UNCY 12.61
  • CCG 1.90

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

Share on Social Networks: